If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Acquisition

6 Jul 2015 07:00

RNS Number : 1831S
Tarsus Group PLC
06 July 2015
 



6 July 2015

Tarsus Group plc

 

AMB Group Joint Venture - Building Scale in South East Asia

 

Tarsus Group plc (LSE: TRS, "Tarsus" or the "Group"), the international business-to-business media group, today announces that it has further strengthened its portfolio and growth prospects in South East Asia by acquiring 50% of the AMB Group via a joint venture vehicle AMB Tarsus Exhibitions Sdn. Bhd. ("AMBT") from Andrew Siow and Richard Yew (the "Vendors") (the "Acquisition").

 

Established in 1996, the AMB Group is a major South-East Asian exhibition organiser with a major presence in Myanmar and Cambodia and a growing business in the region. It has built up a portfolio of market leading exhibitions and conferences in some of Tarsus' key strategic sectors with the largest focused on building, infrastructure, automotive and food processing.

 

AMB Group has enjoyed strong growth in recent years, driven by the establishment of leading events in Myanmar and Cambodia - MyanFood and Cambuild respectively.

 

The partnership adds significant scale and presence across South East Asia, building on Tarsus' existing successful assets in Indonesia - PT Infrastructure Asia and the replication of two Tarsus brands, GESS Indonesia and Table and Home Indonesia. Tarsus intends to scale up AMBT's existing events and launch new exhibitions in its existing markets.

 

As part of its accelerated replication program Tarsus also expects to be able to introduce a number of its leading brands into AMBT's markets of Malaysia, Myanmar and Cambodia. Tarsus will also assist AMBT to access Indonesia by utilising the Group's existing infrastructure in that market.

 

Acquisition highlights

 

· The Vendors, who have over 30 years' experience in the exhibition industry, will continue to manage the business after acquisition.

· The acquisition of 50% of AMBT is for an estimated payment of $13 million (approx. £9 million) in cash of which $4.1 million (approx. £2.6 million) is payable on completion of the Acquisition with a further $4.1 million payable in January 2016 and deferred payments linked to the performance of the business up to the end of 2017. The total consideration for the initial 50% is capped at $20 million (approx. £12.8 million).

· For the year ended 28 February 2015, AMB Group recorded unaudited profit before tax of approximately $2.2 million (approx. £1.4 million) and unaudited gross assets of $2.9 million (£1.8 million).

· The consideration will be met from existing financial resources. To provide additional headroom the Group has increased its bank facilities to £75m (from £60m) and extended the term of the facilities out to July 2020. The other commercial terms of the bank facilities are unchanged.

· The Acquisition is expected to be earnings accretive in the financial year ending 31 December 2015 and thereafter.

· There is a put and call option in respect of the Vendor's remaining 50% stake in AMBT (the "Remaining Stake"). The Vendors will be permitted to sell the Remaining Stake to Tarsus in the event of a sale of at least 50.1% of Tarsus ordinary shares of 5p each collectively held (either directly or beneficially) by both Neville Buch, Chairman and Douglas Emslie, Group Managing Director as at the date of completion. In this circumstance the Vendors may sell their Remaining Stake to Tarsus for a maximum consideration of $25m (approx. £16.1 million) in cash determined in reference to the profit of AMBT in the financial year (31 December) immediately preceding exercise of the option.

 

Douglas Emslie, Tarsus Group Managing Director said:

 

"AMBT is an excellent strategic acquisition and allows Tarsus to build scale in South East Asia with an entrepreneurial partner. Many of the ASEAN economies are growing strongly and the AMBT joint venture will offer us first-mover advantage in some key sectors in these exciting markets.

 

"I have known Andrew Siow for over 20 years and he and Richard have an excellent track record in launching and developing events in the region. Their expertise will add significant strength and depth to the Group's operations in South East Asia. We expect there to be compelling opportunities to replicate Tarsus' leading brands into AMBT's geographic footprint."

 

Tarsus intends to announce its results for the six months ended 30 June 2015 on 29 July 2015.

 

For further information:

 

Tarsus Group plc:

 

Douglas Emslie, Group Managing Director

 + +44 (0)20 8846 2700

Dan O'Brien, Group Finance Director

 

Neville Harris, Investor Relations

+44 (0)7909 976044

 

Notes to editors

Tarsus Group plc (LSE:TRS) is an international business-to-business media group with interests in exhibitions, publishing and online media. The Group operates globally in key verticals including aviation, medical, labels and packaging, discount clothing (Off-Price), housewares and automotive. Tarsus runs more than 80 events and websites and its flagship brands include the Labelexpo exhibitions in Europe, the Americas and Asia and the Dubai Airshow.

 

The Group operates across a worldwide network of offices in Dublin, London, Paris, Milwaukee, Boca Raton (Florida), Dubai, Shanghai, Jakarta, New Delhi and Istanbul. Tarsus is building on its strong presence in the emerging markets of the Middle East, China, Turkey, Indonesia and Mexico.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEXLFBEDFEBBK
Date   Source Headline
17th Mar 20114:31 pmRNSHolding(s) in Company
17th Mar 20114:28 pmRNSAcquisition
10th Mar 201112:00 pmRNSDirector/PDMR Shareholding
7th Mar 20117:00 amRNSFinal Results
21st Jan 201110:42 amRNSAdditional Listing
18th Jan 20114:36 pmRNSHolding(s) in Company
18th Jan 20114:36 pmRNSHolding(s) in Company
6th Jan 20117:00 amRNSTrading Statement
5th Jan 20114:29 pmRNSHolding(s) in Company
5th Jan 20114:27 pmRNSHolding(s) in Company
4th Jan 20117:00 amRNSTotal Voting Rights
20th Dec 20103:02 pmRNSScrip Dividend Circular
30th Nov 20102:37 pmRNSTotal Voting Rights
16th Nov 20107:00 amRNSInterim Management Statement
9th Nov 20104:58 pmRNSBlocklisting Interim Review
17th Sep 20104:55 pmRNSChange of Registered Office
31st Aug 20109:55 amRNSTotal Voting Rights
25th Aug 20106:14 pmRNSHolding(s) in Company
25th Aug 20106:12 pmRNSHolding(s) in Company
25th Aug 20106:11 pmRNSHolding(s) in Company
25th Aug 20106:09 pmRNSHolding(s) in Company
25th Aug 20106:07 pmRNSHolding(s) in Company
23rd Aug 20107:00 amRNSCompletion of Acquisition and Total Voting Rights
20th Aug 20104:14 pmRNSDirector/PDMR Shareholding
19th Aug 20101:50 pmRNSResult of Meeting
18th Aug 201010:55 amRNSInterim Financial Statements 2010
17th Aug 201010:41 amRNSDirector/PDMR Shareholding
30th Jul 201010:53 amRNSTotal Voting Rights
28th Jul 20107:01 amRNSPosting of Circular
28th Jul 20107:00 amRNSInterim Results
26th Jul 20103:22 pmRNSApplication for Admission
5th Jul 20103:55 pmRNSApplication for admission
30th Jun 20107:00 amRNSPre-close Trading Statement
17th Jun 20105:10 pmRNSDirector/PDMR Shareholding
16th Jun 20102:48 pmRNSResult of AGM
7th Jun 20102:31 pmRNSCirc re. Scrip Dividend
14th May 201012:21 pmRNSAmendment to Notice of Annual General Meeting
10th May 20104:58 pmRNSAnnual Information Update
10th May 20107:00 amRNSInterim Management Statement
7th May 201011:14 amRNSBlocklisting Six Monthly Return
30th Apr 201010:05 amRNSTotal Voting Rights
13th Apr 20105:31 pmRNSDirector/PDMR Shareholding
12th Apr 20101:36 pmRNSAnnual Reports and Accounts
9th Apr 20104:44 pmRNSHolding(s) in Company
1st Apr 20104:33 pmRNSNotification of Interests in Shares
31st Mar 20109:48 amRNSTotal Voting Rights
8th Mar 20107:00 amRNSAcquisition
8th Mar 20107:00 amRNSFinal Results
5th Mar 20107:00 amRNSDirectorate Change
22nd Feb 20107:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.